SCHEMBL6002815

SCHEMBL6002815

CCc1csc2cccc(Cl)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
MAPK1 P28482 2/20 0.39
KDM4E B2RXH2 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CA2 P00918 1/20 0.38
MCL1 Q07820 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C19 P33261 1/20 0.38
OGG1 O15527 1/20 0.37
CYP2A6 P11509 2/20 0.36
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36
DRD3 P35462 1/20 0.36
GABRA1 P14867 2/20 0.33
GABRB2 P47870 2/20 0.33
GPR84 Q9NQS5 1/20 0.33
CTSG P08311 1/20 0.33
CMA1 P23946 1/20 0.33
SYK P43405 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15729955 0.81 CYP2A6 (0.53) ALDH1A1MAPK1KDM4EL3MBTL1CA2
SCHEMBL3276608 0.81 CA2 (0.41) ALDH1A1MAPK1KDM4EL3MBTL1CA2
SCHEMBL2090743 0.81 CYP2A6 (0.36) ALDH1A1MAPK1KDM4EL3MBTL1CA2
SCHEMBL13888151 0.79 CTSG (0.47) ALDH1A1CA2CYP1A2CYP2D6CYP2C19
SCHEMBL8584219 0.79 TAAR1 (0.50) CA2OGG1CYP2A6DRD2DRD4
SCHEMBL6003593 0.78 ALDH1A1 (0.39) ALDH1A1KDM4ECA2CYP1A2CYP2D6
SCHEMBL3150930 0.76 LMNA (0.41) ALDH1A1MAPK1MCL1CYP1A2OGG1
SCHEMBL2092548 0.75 CYP2A6 (0.41) ALDH1A1MAPK1KDM4EL3MBTL1MCL1
SCHEMBL2091809 0.74 DRD2 (0.32) CA2OGG1CYP2A6DRD2DRD4
SCHEMBL4644784 0.73 CYP2A6 (0.52) ALDH1A1CA2CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed